298 related articles for article (PubMed ID: 24636230)
1. Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
El Sayed SM; Mohamed WG; Seddik MA; Ahmed AS; Mahmoud AG; Amer WH; Helmy Nabo MM; Hamed AR; Ahmed NS; Abd-Allah AA
Chin J Cancer; 2014 Jul; 33(7):356-64. PubMed ID: 24636230
[TBL] [Abstract][Full Text] [Related]
2. The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view.
El Sayed SM; Baghdadi H; Zolaly M; Almaramhy HH; Ayat M; Donki JG
Med Hypotheses; 2017 Mar; 100():67-77. PubMed ID: 28236852
[TBL] [Abstract][Full Text] [Related]
3. 3-Bromopyruvate as a potent anticancer therapy in honor and memory of the late Professor André Goffeau.
Ko YH; Niedźwiecka K; Casal M; Pedersen PL; Ułaszewski S
Yeast; 2019 Apr; 36(4):211-221. PubMed ID: 30462852
[TBL] [Abstract][Full Text] [Related]
4. A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside.
Ko YH; Verhoeven HA; Lee MJ; Corbin DJ; Vogl TJ; Pedersen PL
J Bioenerg Biomembr; 2012 Feb; 44(1):163-70. PubMed ID: 22328020
[TBL] [Abstract][Full Text] [Related]
5. D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.
El Sayed SM; El-Magd RM; Shishido Y; Yorita K; Chung SP; Tran DH; Sakai T; Watanabe H; Kagami S; Fukui K
J Bioenerg Biomembr; 2012 Oct; 44(5):513-23. PubMed ID: 22802136
[TBL] [Abstract][Full Text] [Related]
6. The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate.
Lis P; Dyląg M; Niedźwiecka K; Ko YH; Pedersen PL; Goffeau A; Ułaszewski S
Molecules; 2016 Dec; 21(12):. PubMed ID: 27983708
[TBL] [Abstract][Full Text] [Related]
7. 3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects.
El Sayed SM; El-Magd RM; Shishido Y; Chung SP; Diem TH; Sakai T; Watanabe H; Kagami S; Fukui K
J Bioenerg Biomembr; 2012 Feb; 44(1):61-79. PubMed ID: 22318356
[TBL] [Abstract][Full Text] [Related]
8. 3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issue.
Pedersen PL
J Bioenerg Biomembr; 2012 Feb; 44(1):1-6. PubMed ID: 22382780
[TBL] [Abstract][Full Text] [Related]
9. Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience.
El Sayed SM
Int J Nanomedicine; 2018; 13():4699-4709. PubMed ID: 30154655
[TBL] [Abstract][Full Text] [Related]
10. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect).
El Sayed SM; Mahmoud AA; El Sawy SA; Abdelaal EA; Fouad AM; Yousif RS; Hashim MS; Hemdan SB; Kadry ZM; Abdelmoaty MA; Gabr AG; Omran FM; Nabo MM; Ahmed NS
Med Hypotheses; 2013 Nov; 81(5):866-70. PubMed ID: 24071366
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria: 3-bromopyruvate vs. mitochondria? A small molecule that attacks tumors by targeting their bioenergetic diversity.
Galina A
Int J Biochem Cell Biol; 2014 Sep; 54():266-71. PubMed ID: 24842108
[TBL] [Abstract][Full Text] [Related]
12. Topical 3-bromopyruvate is a novel targeted therapy for melanoma in a preclinical model.
Yamada M; Kagaya M; Noguchi N; Ueki S; Hasunuma N; Osada SI; Manabe M
J Dermatol Sci; 2018 Nov; 92(2):134-142. PubMed ID: 30206027
[TBL] [Abstract][Full Text] [Related]
13. 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells.
Chiasserini D; Davidescu M; Orvietani PL; Susta F; Macchioni L; Petricciuolo M; Castigli E; Roberti R; Binaglia L; Corazzi L
J Proteomics; 2017 Jan; 152():329-338. PubMed ID: 27890797
[TBL] [Abstract][Full Text] [Related]
14. Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma.
Niedźwiecka K; Dyląg M; Augustyniak D; Majkowska-Skrobek G; Cal-Bąkowska M; Ko YH; Pedersen PL; Goffeau A; Ułaszewski S
Oncotarget; 2016 Oct; 7(40):65614-65626. PubMed ID: 27582536
[TBL] [Abstract][Full Text] [Related]
15. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
[TBL] [Abstract][Full Text] [Related]
16. D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate.
El Sayed SM; Abou El-Magd RM; Shishido Y; Chung SP; Sakai T; Watanabe H; Kagami S; Fukui K
Cancer Gene Ther; 2012 Jan; 19(1):1-18. PubMed ID: 21921941
[TBL] [Abstract][Full Text] [Related]
17. The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression.
Ho N; Morrison J; Silva A; Coomber BL
Biosci Rep; 2016 Jan; 36(1):e00299. PubMed ID: 26740252
[TBL] [Abstract][Full Text] [Related]
18. 3-bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes.
Ehrke E; Arend C; Dringen R
J Neurosci Res; 2015 Jul; 93(7):1138-46. PubMed ID: 25196479
[TBL] [Abstract][Full Text] [Related]
19. Importance of glycolysis and oxidative phosphorylation in advanced melanoma.
Ho J; de Moura MB; Lin Y; Vincent G; Thorne S; Duncan LM; Hui-Min L; Kirkwood JM; Becker D; Van Houten B; Moschos SJ
Mol Cancer; 2012 Oct; 11():76. PubMed ID: 23043612
[TBL] [Abstract][Full Text] [Related]
20. Metastatic melanoma: lactate dehydrogenase levels and CT imaging findings of tumor devascularization allow accurate prediction of survival in patients treated with bevacizumab.
Gray MR; Martin del Campo S; Zhang X; Zhang H; Souza FF; Carson WE; Smith AD
Radiology; 2014 Feb; 270(2):425-34. PubMed ID: 24072776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
